Largest one day gains
The 50 largest one day percentage moves higher recorded at the latest close. The largest moves were 0QF.DE at +15.0% and ONT.L at +9.8%. By size, the list splits into 33 large cap and 17 mid cap listings.
Switch view
All stocks50 of 23,178 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1D return | 1Y return |
|---|---|---|---|---|---|
| 0QF.DE | Moderna, Inc. | $59.07B | Large cap | +14.97% | +550.51% |
| ONT.L | Oxford Nanopore Technologies plc | $2.41B | Mid cap | +9.78% | −2.24% |
| ZEAL.CO | Zealand Pharma A/S | $3.34B | Mid cap | +5.66% | −25.94% |
| DMP.DE | Dermapharm Holding SE | $2.31B | Mid cap | +5.53% | +27.27% |
| COLO-B.CO | Coloplast A/S | $15.96B | Large cap | +5.45% | −20.60% |
| CBHD.DE | Coloplast A/S | $15.94B | Large cap | +4.91% | +7.91% |
| NANO.PA | Nanobiotix S.A. | $2.05B | Mid cap | +4.69% | +358.21% |
| BIOA-B.ST | BioArctic AB (publ) | $3.00B | Mid cap | +4.61% | +12.31% |
| ABVX.PA | ABIVAX Société Anonyme | $10.21B | Large cap | +4.28% | +48.91% |
| 22UA.DE | BioNTech SE | $28.28B | Large cap | +4.11% | +14.09% |
| GMAB.CO | Genmab A/S | $20.69B | Large cap | +3.98% | +36.19% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | $16.99B | Large cap | +3.89% | +61.26% |
| GE9.DE | Genmab A/S | $20.65B | Large cap | +3.85% | −11.12% |
| ILU.DE | Illumina, Inc. | $34.08B | Large cap | +3.28% | +129.80% |
| IDP.DE | Biogen Inc. | $32.39B | Large cap | +3.18% | +65.32% |
| HLUN-A.CO | H. Lundbeck A/S | $6.40B | Mid cap | +3.05% | +29.71% |
| HLUN-B.CO | H. Lundbeck A/S | $6.47B | Mid cap | +2.74% | +8.99% |
| BAVA.CO | Bavarian Nordic A/S | $2.51B | Mid cap | +2.44% | −7.97% |
| PFE.DE | Pfizer Inc. | $161.11B | Large cap | +2.24% | +22.96% |
| ORNBV.HE | Orion Oyj | $13.16B | Large cap | +2.15% | +21.01% |
| IPN.PA | Ipsen S.A. | $15.97B | Large cap | +2.09% | +40.80% |
| ORNAV.HE | Orion Oyj | $13.11B | Large cap | +1.90% | +21.27% |
| BAY.WA | Bayer Aktiengesellschaft | $55.90B | Large cap | +1.84% | +76.59% |
| VIA.DE | Viatris Inc. | $19.41B | Large cap | +1.84% | +67.32% |
| DUL.DE | Alnylam Pharmaceuticals, Inc. | $32.28B | Large cap | +1.75% | −10.21% |
| DIM.PA | Sartorius Stedim Biotech S.A. | $21.78B | Large cap | +1.62% | +11.64% |
| BAYN.DE | Bayer Aktiengesellschaft | $56.25B | Large cap | +1.61% | +76.91% |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | $84.24B | Large cap | +1.56% | −5.91% |
| BIM.PA | bioMérieux S.A. | $10.22B | Large cap | +1.55% | −35.91% |
| GIS.DE | Gilead Sciences, Inc. | $184.35B | Large cap | +1.52% | +33.64% |
| GN.CO | GN Store Nord A/S | $2.13B | Mid cap | +1.52% | −18.50% |
| OBCK.DE | Ottobock SE & Co. KGaA | $4.40B | Mid cap | +1.51% | +0.68% |
| SRT3.DE | Sartorius Aktiengesellschaft | $19.68B | Large cap | +1.40% | +25.88% |
| 22Z.DE | Zealand Pharma A/S | $3.37B | Mid cap | +1.33% | −28.16% |
| BRM.DE | Bristol-Myers Squibb Company | $137.92B | Large cap | +1.20% | +50.84% |
| ERF.PA | Eurofins Scientific SE | $14.64B | Large cap | +1.12% | +15.60% |
| VX1.DE | Vertex Pharmaceuticals Incorporated | $139.82B | Large cap | +1.07% | +41.64% |
| BV3.DE | Bavarian Nordic A/S | $2.55B | Mid cap | +1.04% | +15.65% |
| SRT.DE | Sartorius Aktiengesellschaft | $15.54B | Large cap | +1.04% | +21.79% |
| CAMX.ST | Camurus AB (publ) | $3.79B | Mid cap | +0.90% | −15.35% |
| GS71.DE | GSK plc | $103.63B | Large cap | +0.86% | +34.79% |
| QIA.DE | Qiagen N.V. | $8.99B | Mid cap | +0.84% | −6.73% |
| EKTA-B.ST | Elekta AB (publ) | $2.20B | Mid cap | +0.81% | +26.10% |
| GSK.L | GSK plc | $104.16B | Large cap | +0.79% | +30.59% |
| 56S1.DE | Sartorius Stedim Biotech S.A. | $21.77B | Large cap | +0.78% | +11.32% |
| MRK.DE | Merck KGaA | $70.28B | Large cap | +0.69% | +32.17% |
| MCOV-B.ST | Medicover AB (publ) | $3.85B | Mid cap | +0.62% | −8.20% |
| SAN.PA | Sanofi | $109.36B | Large cap | +0.59% | −2.60% |
| HCM.L | HUTCHMED (China) Limited | $2.16B | Mid cap | +0.56% | −18.08% |
| SNW.DE | Sanofi | $109.40B | Large cap | +0.55% | −2.82% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Micro and small cap listings are left out, so the list describes the market rather than thin trading, as are moves beyond 1,000% in a session, which are corporate actions the price series has not been restated for. This is a description of one day of price movement, nothing more. It says nothing about any company behind it.